|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date31 Oct 1989 |
100 Clinical Results associated with Shanxi Bokang Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Shanxi Bokang Pharmaceutical Co. Ltd.
100 Deals associated with Shanxi Bokang Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Shanxi Bokang Pharmaceutical Co. Ltd.